IL112424A0 - Modified oligonucleotides and pharmaceutical compositions containing them - Google Patents
Modified oligonucleotides and pharmaceutical compositions containing themInfo
- Publication number
- IL112424A0 IL112424A0 IL11242495A IL11242495A IL112424A0 IL 112424 A0 IL112424 A0 IL 112424A0 IL 11242495 A IL11242495 A IL 11242495A IL 11242495 A IL11242495 A IL 11242495A IL 112424 A0 IL112424 A0 IL 112424A0
- Authority
- IL
- Israel
- Prior art keywords
- pct
- pharmaceutical compositions
- compositions containing
- modified oligonucleotides
- nucleotides
- Prior art date
Links
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Chemical class Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002777 nucleoside Substances 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 125000003835 nucleoside group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9401446A GB9401446D0 (en) | 1994-01-26 | 1994-01-26 | Modified oligonucleotides |
| GB9412526A GB9412526D0 (en) | 1994-06-22 | 1994-06-22 | Modified oligonucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL112424A0 true IL112424A0 (en) | 1995-03-30 |
Family
ID=26304218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11242495A IL112424A0 (en) | 1994-01-26 | 1995-01-24 | Modified oligonucleotides and pharmaceutical compositions containing them |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6066447A (da) |
| EP (1) | EP0741741B1 (da) |
| JP (1) | JPH09508134A (da) |
| AT (1) | ATE222921T1 (da) |
| AU (1) | AU697134B2 (da) |
| CA (1) | CA2180727A1 (da) |
| DE (1) | DE69527942T2 (da) |
| DK (1) | DK0741741T3 (da) |
| FI (1) | FI116677B (da) |
| HU (1) | HU220423B (da) |
| IL (1) | IL112424A0 (da) |
| NO (1) | NO316902B1 (da) |
| WO (1) | WO1995020597A1 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2144603T5 (es) * | 1993-12-13 | 2004-11-16 | THE PROCTER & GAMBLE COMPANY | Composiciones liquidas concentradas, de viscosidad estable, de suavizante para materiales textiles. |
| US6166197A (en) * | 1995-03-06 | 2000-12-26 | Isis Pharmaceuticals, Inc. | Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions |
| US6222025B1 (en) | 1995-03-06 | 2001-04-24 | Isis Pharmaceuticals, Inc. | Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom |
| WO1997014709A1 (en) * | 1995-10-13 | 1997-04-24 | F. Hoffmann-La Roche Ag | Antisense oligomers |
| US5808035A (en) * | 1995-12-08 | 1998-09-15 | Usher; David A. | Protected nucleoside and method for its synthesis |
| WO1998000434A1 (en) * | 1996-06-28 | 1998-01-08 | Novartis Ag | Modified oligonucleotides |
| PL337888A1 (en) | 1997-07-03 | 2000-09-11 | Du Pont Pharm Co | Imidazoprimidines and imidazopyridines for use in treating neurological disorders |
| US6686366B1 (en) | 1998-06-02 | 2004-02-03 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| HUP0103836A3 (en) | 1998-06-02 | 2003-05-28 | Osi Pharmaceuticals Inc Uniond | Pyrrolo[2,3d]pyrimidine compositions and their use |
| US6878716B1 (en) | 1998-06-02 | 2005-04-12 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptor and uses thereof |
| US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
| US7160890B2 (en) | 1999-12-02 | 2007-01-09 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US6680322B2 (en) | 1999-12-02 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| US6664252B2 (en) | 1999-12-02 | 2003-12-16 | Osi Pharmaceuticals, Inc. | 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof |
| US6673802B2 (en) | 2000-12-01 | 2004-01-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US6680324B2 (en) | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| DE60234118D1 (de) | 2001-11-30 | 2009-12-03 | Osi Pharm Inc | Verbindungen, die für Adenosin A1 und A3 Rezeptoren spezifisch sind, und deren Anwendungen |
| US20030229067A1 (en) | 2001-12-20 | 2003-12-11 | Arlindo Castelhano | Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| ATE458483T1 (de) | 2001-12-20 | 2010-03-15 | Osi Pharm Inc | Selektive pyrimidin-a2b-antagonistenverbindungen, ihre synthese und verwendung |
| KR100649352B1 (ko) * | 2005-04-30 | 2006-11-27 | 주식회사 하이닉스반도체 | 반도체소자의 제조 방법 |
| US7820810B2 (en) | 2007-03-19 | 2010-10-26 | Isis Pharmaceuticals, Inc. | Process for the synthesis of 2′-O-substituted purine nulceosides |
| MX2011010050A (es) | 2009-03-25 | 2011-12-14 | Univ Texas | Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos. |
| WO2016044839A2 (en) | 2014-09-19 | 2016-03-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
| JP6981961B2 (ja) * | 2015-07-30 | 2021-12-17 | ホライズン オルファン エルエルシー | フコシダーゼ阻害剤 |
| WO2025149479A1 (en) * | 2024-01-12 | 2025-07-17 | Roche Diagnostics Gmbh | Synthesis of modified nucleoside triphosphates |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
| EP0266099A3 (en) * | 1986-10-28 | 1990-09-19 | The Johns Hopkins University | Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids |
| WO1989008146A1 (en) * | 1988-02-26 | 1989-09-08 | Worcester Foundation For Experimental Biology | Inhibition of htlv-iii by exogenous oligonucleotides |
| DK0942000T3 (da) * | 1989-10-24 | 2004-11-01 | Isis Pharmaceuticals Inc | 2'-modificerede oligonukleotider |
| US5378825A (en) * | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
| ATE131827T1 (de) * | 1990-08-03 | 1996-01-15 | Sterling Winthrop Inc | Verbindungen und verfahren zur unterdrückung der genexpression |
| EP0549686A4 (en) * | 1990-09-20 | 1995-01-18 | Gilead Sciences Inc | Modified internucleoside linkages |
-
1995
- 1995-01-17 JP JP7519861A patent/JPH09508134A/ja active Pending
- 1995-01-17 AU AU15347/95A patent/AU697134B2/en not_active Ceased
- 1995-01-17 EP EP95906958A patent/EP0741741B1/en not_active Expired - Lifetime
- 1995-01-17 WO PCT/EP1995/000156 patent/WO1995020597A1/en not_active Ceased
- 1995-01-17 AT AT95906958T patent/ATE222921T1/de not_active IP Right Cessation
- 1995-01-17 DK DK95906958T patent/DK0741741T3/da active
- 1995-01-17 US US08/687,456 patent/US6066447A/en not_active Expired - Fee Related
- 1995-01-17 CA CA002180727A patent/CA2180727A1/en not_active Abandoned
- 1995-01-17 HU HU9602040A patent/HU220423B/hu not_active IP Right Cessation
- 1995-01-17 DE DE69527942T patent/DE69527942T2/de not_active Expired - Fee Related
- 1995-01-24 IL IL11242495A patent/IL112424A0/xx unknown
-
1996
- 1996-07-24 NO NO19963092A patent/NO316902B1/no unknown
- 1996-07-26 FI FI962980A patent/FI116677B/fi active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| HUT75704A (en) | 1997-05-28 |
| HU220423B (hu) | 2002-01-28 |
| WO1995020597A1 (en) | 1995-08-03 |
| NO963092D0 (no) | 1996-07-24 |
| EP0741741A1 (en) | 1996-11-13 |
| EP0741741B1 (en) | 2002-08-28 |
| AU1534795A (en) | 1995-08-15 |
| NO963092L (no) | 1996-09-16 |
| DE69527942T2 (de) | 2003-03-27 |
| FI962980A0 (fi) | 1996-07-26 |
| CA2180727A1 (en) | 1995-08-03 |
| HU9602040D0 (en) | 1996-09-30 |
| FI962980L (fi) | 1996-07-26 |
| FI116677B (fi) | 2006-01-31 |
| US6066447A (en) | 2000-05-23 |
| DK0741741T3 (da) | 2002-12-23 |
| JPH09508134A (ja) | 1997-08-19 |
| AU697134B2 (en) | 1998-09-24 |
| ATE222921T1 (de) | 2002-09-15 |
| DE69527942D1 (de) | 2002-10-02 |
| NO316902B1 (no) | 2004-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112424A0 (en) | Modified oligonucleotides and pharmaceutical compositions containing them | |
| MX9703192A (es) | Nucleosidos modificados en el azucar y su uso para la sintesis de oligonucleosidos. | |
| MX9702932A (es) | L-ribofuranosilnucleosidos. | |
| HU9501963D0 (en) | 7-deazapurine modified oligonucleotides | |
| CA2167361A1 (en) | 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides | |
| CA2220418A1 (en) | Oligonucleotide sizing using cleavable primers | |
| ZA964547B (en) | Monkey monocional antibodies specific to human b7.1 and/or b7.2, primatized forms thereof pharmaceutical compositions containing them and use thereof as immunosuppressants | |
| EP0977767A4 (en) | AMINOOXY MODIFIED OLIGONUCLEOTIDES | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
| TW349095B (en) | Taxoids, their preparation and pharmaceutical compositions which contain them | |
| GR3030733T3 (en) | Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them | |
| AU4848793A (en) | Oligonucleotide and nucleotide amine analogs, methods of synthesis and use | |
| IL136895A0 (en) | Novel pharmaceutical compositions of uridine triphosphate | |
| ZA974952B (en) | 2'-substituted nucleosides and oligonucleotide derivatives. | |
| MX9702926A (es) | L-eritrosilnucleosidos. | |
| MX9800049A (es) | Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso. | |
| DK0644196T3 (da) | TTTr som beskyttelsesgruppe i nucleotidsyntesen | |
| EP0305972A3 (en) | 3'- demethoxyepipodophyllotoxin glucoside derivatives | |
| AU8239891A (en) | 5'-hydrogenphosphonates and 5'-methylphosphonates of sugar modified nucleosides, compositions and uses thereof | |
| IL105454A0 (en) | Water-soluble retinoids,their preparation and pharmaceutical and cosmetic compositions containing them | |
| MX9702927A (es) | L-piranosilnucleosidos. | |
| HUP9901975A3 (en) | Novel n,n'-bridged bis-indolyl-maleimides, their use as intermediates and pharmaceutical compositions containing them | |
| AU2739797A (en) | (in situ) preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides | |
| DK0611373T3 (da) | Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning. |